APA (7th ed.) Citation

Sakurai, H., Goto, M., Takenaka-Ninagawa, N., Harada, A., & Ikeya, M. (2024). 07P Development of cell therapy for Ullrich congenital muscular dystrophy by iPSC-derived mesenchymal stromal cell. Neuromuscular Disorders, 43, N.PAG. https://doi.org/10.1016/j.nmd.2024.07.214

Chicago Style (17th ed.) Citation

Sakurai, H., M. Goto, N. Takenaka-Ninagawa, A. Harada, and M. Ikeya. "07P Development of Cell Therapy for Ullrich Congenital Muscular Dystrophy by IPSC-derived Mesenchymal Stromal Cell." Neuromuscular Disorders 43 (2024): N.PAG. https://doi.org/10.1016/j.nmd.2024.07.214.

MLA (9th ed.) Citation

Sakurai, H., et al. "07P Development of Cell Therapy for Ullrich Congenital Muscular Dystrophy by IPSC-derived Mesenchymal Stromal Cell." Neuromuscular Disorders, vol. 43, 2024, p. N.PAG, https://doi.org/10.1016/j.nmd.2024.07.214.